Pan Li

Person

  • Arlington, MA, US

Patents Grantslast 30 patents

  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 11,813,267
    • Issue date Nov 14, 2023
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Pteridinone compounds and uses thereof

    • Patent number 11,572,364
    • Issue date Feb 7, 2023
    • Vertex Pharmaceuticals Incorporated
    • David Lauffer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Antiproliferation compounds and uses thereof

    • Patent number 11,440,907
    • Issue date Sep 13, 2022
    • Merck Patent GmbH
    • Henry Yu
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Pteridinone compounds and uses thereof

    • Patent number 11,059,826
    • Issue date Jul 13, 2021
    • Vertex Pharmaceuticals Incorporated
    • David J. Lauffer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 11,021,465
    • Issue date Jun 1, 2021
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 11,008,305
    • Issue date May 18, 2021
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted quinoxaline DNA-PK inhibitors

    • Patent number 10,973,830
    • Issue date Apr 13, 2021
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Antiproliferation compounds and uses thereof

    • Patent number 10,815,225
    • Issue date Oct 27, 2020
    • Merck Patent GmbH
    • Henry Yu
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,786,512
    • Issue date Sep 29, 2020
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,501,439
    • Issue date Dec 10, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,442,791
    • Issue date Oct 15, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,391,095
    • Issue date Aug 27, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,258,627
    • Issue date Apr 16, 2019
    • Vertex Pharmaceutical Incorporated
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,076,521
    • Issue date Sep 18, 2018
    • Vertex Pharamceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted benzooxadiazole DNA-PK inhibitors

    • Patent number 9,987,284
    • Issue date Jun 5, 2018
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors and uses thereof

    • Patent number 9,925,188
    • Issue date Mar 27, 2018
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors for treatment of cancer

    • Patent number 9,878,993
    • Issue date Jan 30, 2018
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 9,592,232
    • Issue date Mar 14, 2017
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 9,376,448
    • Issue date Jun 28, 2016
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 9,359,380
    • Issue date Jun 7, 2016
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Substituted quinoxaline DNA-PK inhibitors

    • Patent number 9,340,557
    • Issue date May 17, 2016
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 9,296,701
    • Issue date Mar 29, 2016
    • Vertex Pharmaceuticals Incorporated
    • Paul S Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Triazole compounds useful as protein kinase inhibitors

    • Patent number 8,633,210
    • Issue date Jan 21, 2014
    • Vertex Pharmaceuticals Incorporated
    • Jean-Damien Charrier
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful...

    • Patent number 8,524,720
    • Issue date Sep 3, 2013
    • Vertex Pharmaceuticals Incorporated
    • David Bebbington
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    c-MET protein kinase inhibitors

    • Patent number 8,518,938
    • Issue date Aug 27, 2013
    • Vertex Pharmaceuticals Incorporated
    • David J. Lauffer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    c-MET protein kinase inhibitors

    • Patent number 8,481,524
    • Issue date Jul 9, 2013
    • Vertex Pharmaceuticals Incorporated
    • David Lauffer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Heterocyclic inhibitors of c-Met and uses thereof

    • Patent number 8,481,538
    • Issue date Jul 9, 2013
    • Vertex Pharmaceuticals Incorporated
    • Alexander Aronov
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Triazolothiadiazole inhibitor of c-Met protein kinase

    • Patent number 8,343,998
    • Issue date Jan 1, 2013
    • Vertex Pharmaceuticals Incorporated
    • David J. Lauffer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase

    • Patent number 8,269,012
    • Issue date Sep 18, 2012
    • Vertex Pharmaceuticals Incorporated
    • David Lauffer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted pyrazole inhibitors of c-Met protein kinase

    • Patent number 8,269,013
    • Issue date Sep 18, 2012
    • Vertex Pharmaceuticals Incorporated
    • Pan Li
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    PTERIDINONE COMPOUNDS AND USES THEREOF

    • Publication number 20230312587
    • Publication date Oct 5, 2023
    • Vertex Pharmaceutical Incorporated
    • David LAUFFER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS

    • Publication number 20230277547
    • Publication date Sep 7, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ANTIPROLIFERATION COMPOUNDS AND USES THEREOF

    • Publication number 20230150993
    • Publication date May 18, 2023
    • Merck Patent GmbH
    • Henry YU
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    PTERIDINONE COMPOUNDS AND USES THEREOF

    • Publication number 20220363685
    • Publication date Nov 17, 2022
    • VERTEX PHARMACEUTICALS INCORPORATED
    • David LAUFFER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS

    • Publication number 20210236505
    • Publication date Aug 5, 2021
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20210069203
    • Publication date Mar 11, 2021
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20200109130
    • Publication date Apr 9, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20200062732
    • Publication date Feb 27, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20190290654
    • Publication date Sep 26, 2019
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20190255062
    • Publication date Aug 22, 2019
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20180325898
    • Publication date Nov 15, 2018
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20180311254
    • Publication date Nov 1, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20180208579
    • Publication date Jul 26, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20180193341
    • Publication date Jul 12, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20180161336
    • Publication date Jun 14, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20170258789
    • Publication date Sep 14, 2017
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20160368899
    • Publication date Dec 22, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20160354381
    • Publication date Dec 8, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20160340341
    • Publication date Nov 24, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20160250212
    • Publication date Sep 1, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20150111871
    • Publication date Apr 23, 2015
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20140275059
    • Publication date Sep 18, 2014
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20140275024
    • Publication date Sep 18, 2014
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRID...

    • Publication number 20140065103
    • Publication date Mar 6, 2014
    • Vertex Pharmaceuticals Incorporated.
    • Jeremy Green
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20140045869
    • Publication date Feb 13, 2014
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20130281431
    • Publication date Oct 24, 2013
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS...

    • Publication number 20130190289
    • Publication date Jul 25, 2013
    • Vertex Pharmaceuticals Incorporated.
    • Jeremy Green
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    AMINOPYRAZOLE TRIAZOLOTHIADIAZOLE INHIBITORS OF C-MET PROTEIN KINASE

    • Publication number 20130018072
    • Publication date Jan 17, 2013
    • Vertex Pharmaceuticals Incorporated.
    • David Lauffer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    C-MET PROTEIN KINASE INHIBITORS

    • Publication number 20120165333
    • Publication date Jun 28, 2012
    • Vertex Pharmaceuticals Incorporated.
    • David J. Lauffer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS

    • Publication number 20120071657
    • Publication date Mar 22, 2012
    • Vertex Pharmaceuticals Incorporated.
    • David Bebbington
    • C07 - ORGANIC CHEMISTRY